CRNX
CRNX
NASDAQ · Pharmaceuticals

Crinetics Pharmaceuticals In

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$34.37
-0.34 (-0.98%)
As of Mar 24, 9:54 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +43.7% upside
Low Target $38.77
Average Target $49.40
High Target $74.88
Current Price $34.37
Current
$34.37
Target
$49.40
$38.77 $49.40 avg $74.88
Scenario Analysis
Bear Case
$38.77
12.8%
Low target
Base Case
$49.40
+43.7%
Avg target
Bull Case
$74.88
+117.9%
High target
Risk/Reward
9.2x
Highly favorable
Price in Context
52-Week High
$57.99
-40.7% from high
52-Week Low
$24.10
+42.6% from low
50-Day SMA
$49.40
-30.4% vs SMA
200-Day SMA
$38.81
-11.4% vs SMA
RSI (14)
27.9
Oversold
Target vs 52W High
$49.40
-14.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +47.3%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +27.3%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +36.9%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +25.7%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +204.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +81.0%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -20.4%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +819.3%